Balcoltra - (0.1 mg/0.02 mg Tablet)

Generic Name	Levonorgestrel and Ethinyl Estradiol	Innovator	Avion pharma
Dosage	0.1 mg/0.02 mg Tablet	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Balcoltra is a progestin/estrogen COC indicated for use by females of reproductive potential to prevent pregnancy.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*****	*** \ **	*** **, ****	*******	********	******* *** **** *** *** ****
*******	** \ **	-**-	*** *********	********	******** ** *** **, ****

Chronology Of Events